期刊文献+

P53蛋白表达水平与大肠腺癌病理及预后的探讨

Study of the Relation Between P53 Expression and Pathological Factors in Colorectal Carcinoma and It,s Prognostic Significance
全文增补中
导出
摘要 应用免疫组织化学方法对40例大肠腺癌P53蛋白表达进行检查,探讨P53蛋白表达水平与大肠腺癌各病理因素及预后的关系。发现50%(20/40)大肠腺癌组织中存在P53蛋白表达,其表达程度与大肠腺癌各项病理因素无关;P53蛋白表达阳性患者5年生存率为25%(5/20),明显低于P53蛋白表达阴性组的60%(12/20),P<0.05。结果提示:P53免疫组化检测可以作为判断大肠腺癌预后的指标。 ? The expression of P53 protein in 40 cases of large bowel adenocarcinoma was studied immunohistochemically by use of a monoclonal antibody DO7 in this study. And immunoreactivity was found in 50% of them. The pattern of P53 expression was mainly detected in the nuclei of the tumor cells. No significant correlation between the expression of P53 and tumor size, pattern of growth, differention or lymph node metastasis was found. However patients with P53 positive tumors had a greater relative risk of death compared with those with P53 negative tumors. The 5 year survival rate was 25% of 20 patients with P53 positive tumors and 65% of the patients with P53 negative tumor. There was a significant different in the rate between the two groups of patients(P<0.05).The result suggest that the immunoreactivity of P53 may be act as a prognostic indicator in adenocarcinoma of large bowel.
出处 《湖北医科大学学报》 1998年第1期7-9,共3页
关键词 肠肿瘤 腺癌/病理学 抑癌基因 免疫组化 预后 MeSH intestinal neoplasms adenocarcinoma/PA gene expression regulation prognosis
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部